Waddill William D. insider trades
Waddill William D. has filed 35 Form 4s with the SEC that we hold, for Protagonist Therapeutics, Inc (PTGX) (Director), Arrowhead Pharmaceuticals, INC. (ARWR) (Director), Annexon, Inc. (ANNX) (Director) and TSBX (Director). Across all of them we count 0 purchases worth $0 and 24 sales worth $8.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 7 sales ($5.2M). The largest single trade was a sale of 20,000 shares of Protagonist Therapeutics, Inc worth $1.7M, dated 2026-02-06. The first filing on our record is dated 2021-08-16 and the latest 2026-06-25.
Protagonist Therapeutics, Inc (PTGX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-03-01 | S, sale reported on Form 4 | 12,975 | $406.6K | 2024-03-01 |
| 2024-06-07 | S, sale reported on Form 4 | 8,000 | $280.0K | 2024-06-11 |
| 2024-07-24 | S, sale reported on Form 4 | 8,000 | $320.0K | 2024-07-26 |
| 2024-09-10 | S, sale reported on Form 4 | 8,000 | $360.0K | 2024-09-12 |
| 2025-03-17 | S, sale reported on Form 4 | 4,000 | $217.0K | 2025-03-19 |
| 2025-08-27 | S, sale reported on Form 4 | 4,000 | $237.0K | 2025-08-29 |
| 2025-09-22 | S, sale reported on Form 4 | 4,000 | $257.0K | 2025-09-24 |
| 2025-10-10 | S, sale reported on Form 4 | 8,000 | $702.5K | 2025-10-14 |
| 2025-10-10 | S, sale reported on Form 4 | 4,000 | $277.0K | 2025-10-14 |
| 2026-02-06 | S, sale reported on Form 4 | 20,000 | $1.7M | 2026-02-06 |
| 2026-05-29 | S, sale reported on Form 4 | 9,000 | $896.8K | 2026-06-01 |
| 2026-06-10 | S, sale reported on Form 4 | 9,000 | $969.1K | 2026-06-11 |
| 2026-06-23 | S, sale reported on Form 4 | 9,000 | $1.1M | 2026-06-25 |
Arrowhead Pharmaceuticals, INC. (ARWR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-03 | S, sale reported on Form 4 | 2,100 | $134.9K | 2022-01-04 |
| 2022-01-03 | S, sale reported on Form 4 | 272 | $18.0K | 2022-01-04 |
| 2022-01-03 | S, sale reported on Form 4 | 2,128 | $138.3K | 2022-01-04 |
| 2023-01-09 | S, sale reported on Form 4 | 3,200 | $96.0K | 2023-01-11 |
| 2024-01-11 | S, sale reported on Form 4 | 1,300 | $50.2K | 2024-01-16 |
| 2024-01-11 | S, sale reported on Form 4 | 2,634 | $99.6K | 2024-01-16 |
| 2024-12-16 | S, sale reported on Form 4 | 3,748 | $82.1K | 2024-12-18 |
| 2024-12-17 | S, sale reported on Form 4 | 3,747 | $82.6K | 2024-12-18 |
| 2025-12-19 | S, sale reported on Form 4 | 5,451 | $370.7K | 2025-12-23 |
| 2025-12-19 | S, sale reported on Form 4 | 2,416 | $161.1K | 2025-12-23 |
| 2025-12-19 | S, sale reported on Form 4 | 500 | $34.3K | 2025-12-23 |
Annexon, Inc. (ANNX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TSBX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1553338) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms